Agenda Topics- ADME and Metabolomics
- ADME Optimisation for Drug Design/Discovery
- Genotoxicity and Toxicokinetic Modeling
- New Therapeutic Targets in Drug Design/Discovery
- Pharmacogenomics and Drug Safety
- Regulatory Issues in ADME
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
SpeakersAmiram Goldblum, Head, Hebrew University of Jerusalem Urs Meyer, Emeritus Professor, Biozentrum/University of Basel Richard Walmsley, Professor, University of Manchester/Gentronix Ltd Richard Barton, Research Fellow, Imperial College London Michael Kranz, Computational Chemist, GlaxoSmithKline John Dearden, Emeritus Professor of Medicinal Chemistry, Liverpool John Moores University Mark Cronin, Professor, Liverpool John Moores University Monika Vastag, Laboratory Head, Gedeon Richter Plc Christopher Goldring, Senior Lecturer, University of Liverpool Frederick Tam, Reader/Associate Professor, Imperial College London Sandra Coecke, Laboratory Leader, Joint Research Center
|